Candice Krieger is a Business Editor at This Is Money. She specializes in the intersection of technology and finance, with a focus on AI and machine learning, cybersecurity, and financial technology. Her insights and analyses have been featured in prominent publications including The Jewish News, Daily Mail, and MSN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Israel (National)
Not enough data
Candice Krieger's coverage is heavily focused on press releases and government announcements, particularly pertaining to Israel and technology. She has a keen interest in stories related to funding, big tech, and content & publishing.
Given her focus on national (United Kingdom) news with articles centered around Israel, she may be interested in pitches that provide insights into UK-Israel relations or highlight the impact of Israeli developments within the UK's tech or business landscape.
Pitches offering commentary from authoritative figures within the UK’s political or technological spheres regarding Israeli investments or initiatives could align well with Candice’s coverage interests.
This information evolves through artificial intelligence and human feedback. Improve this profile .
New government figures show Israeli companies launched 16 investment projects in Britain during 2025/26, placing Israel ahead of every G7 nation on a per-capita basis
Steven Tananbaum discussed AI, philanthropy and tackling antisemitism with former Times editor James Harding at Jewish Care's 105th Business Breakfast
As heatwaves become more frequent, what can the UK learn from Israel's decades of innovation in climate resilience?
In his new book, analyst Meir Valman argues that the familiar explanations for Israel's tech success only tell part of the story
By: Candice Krieger
Israeli and Israeli-founded companies make up a third of the first global cohort chosen for Google's Gemini Startup Forum
By: Candice Krieger
The Claude developer is eyeing its biggest acquisition as the race to build more efficient AI intensifies
Dr Noam Solomon's Immunai has raised nearly $270m and works with the world's top 20 pharmaceutical companies, including AstraZeneca, Pfizer and Teva
Simon Rubinsohn says mortgage costs and uncertainty continue to weigh on buyers as London flat prices fall almost 10%
Clalit Health Services' framework for assessing AI before it reaches patients has been highlighted in a new World Health Organisation report
By: Candice Krieger
The AI company has has raised $550 million in one of the year's largest technology funding rounds
